Showing results (171-180 of 356) with videos related to
Sort By:
Pageof 36
Journal of Neuropathology and Experimental Neurology|December 24, 2008
Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathyChristian Wüthrich, Yi Min Cheng, Jeffrey T Joseph, et al.Oncotarget|March 13, 2015
Plexin-B2 promotes invasive growth of malignant gliomaAudrey P Le, Yong Huang, Sandeep C Pingle, et al.Neuro-Oncology Practice|November 18, 2024
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence databaseMichael P Castro, Jameson Quinn, Asher Wasserman, et al.Neoplasia (New York, N.Y.)|December 25, 2008
Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivoTatiana V Kolesnikova, Alexander R Kazarov, Madeleine E Lemieux, et al.Journal of Neurosurgery|July 5, 2011
Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled studyNing Lin, Ian F Dunn, Michael Glantz, et al.Journal of Alzheimer'S Disease : JAD|February 18, 2025
Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's diseaseMilan Fiala, Bruce D Hammock, Sung Hee Hwang, et al.North Carolina Medical Journal|October 28, 2024
A Health Care Clinical Data Platform for Rapid Deployment of Artificial Intelligence and Machine Learning Algorithms for Cancer Care and Oncology Clinical TrialsSoma Sengupta, Rohan Rao, Zachary Kaufman, et al.Oncotarget|May 4, 2017
IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65Shruti Bhargava, Abhirami Visvanathan, Vikas Patil, et al.The Journal of Clinical Investigation|August 5, 2008
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteinsDavid S Ziegler, Renee D Wright, Santosh Kesari, et al.Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.Pageof 36